These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 26944376

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ibandronate treatment in Paget's disease of bone.
    Grauer A, Heichel S, Knaus J, Dosch E, Ziegler R.
    Bone; 1999 May; 24(5 Suppl):87S-89S. PubMed ID: 10321936
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R, Holz G, Minne H, Delling G.
    Verh Dtsch Ges Inn Med; 1978 May; (84):1122-5. PubMed ID: 741902
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Paget's disease of the bone: a report of three cases.
    Bhatt K, Balakrishnan C, Mangat G, Bajan K, Ashavaid T, Joshi VR.
    J Assoc Physicians India; 2006 Jul; 54():571-4. PubMed ID: 17089908
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Paget's disease of bone: diagnosis and treatment].
    Winter EM, Hamdy NA, de Jongh RT, Eekhoff EM, Zillikens MC, Appelman-Dijkstra NM.
    Ned Tijdschr Geneeskd; 2016 Mar; 160():D254. PubMed ID: 27650015
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ, Sternon J.
    Rev Med Brux; 2005 Mar; 26(6):513-7. PubMed ID: 16454155
    [Abstract] [Full Text] [Related]

  • 36. A classical presentation of Paget disease of bone.
    Sheane BJ, Delaney H, Doran MF, Cunnane G.
    J Clin Rheumatol; 2008 Dec; 14(6):373. PubMed ID: 19060670
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 38. Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
    Polyzos SA.
    Clin Rheumatol; 2011 Jan 01; 30(1):149-50. PubMed ID: 21053036
    [No Abstract] [Full Text] [Related]

  • 39. Magnetic resonance imaging presentation of lytic Paget's disease of the cervical spine.
    Sprecher S, Steinberg R, Lichtenstein D, Witt KM, Barginear M.
    J Bone Miner Res; 2002 Nov 01; 17(11):1929-30. PubMed ID: 12412798
    [No Abstract] [Full Text] [Related]

  • 40. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
    Peris P, Alvarez L, Vidal S, Martínez MA, Monegal A, Guañabens N.
    Clin Exp Rheumatol; 2007 Nov 01; 25(2):206-10. PubMed ID: 17543143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.